Terms: = Leukemia AND SMO, Q99835, 6608, ENSG00000128602, SMOH, Gx AND Diagnosis
5 results:
1. PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase.
Alonso-Dominguez JM; Casado LF; Anguita E; Gomez-Casares MT; Buño I; Ferrer-Marín F; Arenas A; Del Orbe R; Ayala R; Llamas P; Salgado RN; Osorio S; Sanchez-Godoy P; Burgaleta C; Mahíllo-Fernández I; Garcia-Gutierrez V; Steegmann JL; Martinez-Lopez J
PLoS One; 2017; 12(7):e0181366. PubMed ID: 28704552
[TBL] [Abstract] [Full Text] [Related]
2. [Current diagnosis and treatment for acute myeloid leukemia].
Kobayashi Y
Rinsho Ketsueki; 2017; 58(4):364-372. PubMed ID: 28484168
[TBL] [Abstract] [Full Text] [Related]
3. Targeting of the signal transducer smo links microRNA-326 to the oncogenic Hedgehog pathway in CD34+ CML stem/progenitor cells.
Babashah S; Sadeghizadeh M; Hajifathali A; Tavirani MR; Zomorod MS; Ghadiani M; Soleimani M
Int J Cancer; 2013 Aug; 133(3):579-89. PubMed ID: 23341351
[TBL] [Abstract] [Full Text] [Related]
4. Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status.
Cea M; Cagnetta A; Cirmena G; Garuti A; Rocco I; Palermo C; Pierri I; Reverberi D; Nencioni A; Ballestrero A; Gobbi M; Carella AM; Patrone F
Leuk Lymphoma; 2013 Feb; 54(2):342-52. PubMed ID: 22762548
[TBL] [Abstract] [Full Text] [Related]
5. Metastatic basal cell carcinoma in the era of hedgehog signaling pathway inhibitors.
Weiss GJ; Korn RL
Cancer; 2012 Nov; 118(21):5310-9. PubMed ID: 22511370
[TBL] [Abstract] [Full Text] [Related]
